Summit Therapeutics (SMMT) Debt Ratio (2022 - 2024)

Summit Therapeutics has reported Debt Ratio for 3 years, with the latest figure at 0.57 in Q1 2024.

• For the quarter ending Q1 2024, Debt Ratio rose 44.19% year-over-year to 0.57; the trailing twelve-month figure through Mar 2024 stood at 0.57 (up 44.19% YoY), and the FY2023 full-year result was 0.49, down 33.83% from the prior year.
• Debt Ratio for Q1 2024 stood at 0.57, up from 0.49 in the prior quarter.
• The five-year high for Debt Ratio was 0.74 in Q4 2022, with the low at 0.22 in Q1 2022.
• Historically, Debt Ratio has averaged 0.44 across 3 years, with a median of 0.42 in 2023.
• The largest YoY upside for Debt Ratio was 82.37% in 2023 against a maximum downside of 33.83% in 2023.
• Summit Therapeutics' Debt Ratio stood at 0.74 in 2022, then plunged by 33.83% to 0.49 in 2023, then grew by 14.8% to 0.57 in 2024.
• The last three Debt Ratio figures came in at 0.57 (Q1 2024), 0.49 (Q4 2023), and 0.42 (Q2 2023), per Business Quant data.